Search Results | Cancer Research | American Association for Cancer Research

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Abstract 1490: Development of a 5-FU modified miR-129 mimic as a novel therapeutic for non-small cell lung cancer

Ga-Ram Hwang, John G. Yuen, Hannah Farley, Jingfang Ju

Cancer Res (2022) 82 (12_Supplement): 1490.

DOI: https://doi.org/10.1158/1538-7445.AM2022-1490

Published: 15 June 2022

View article

Journal Articles

Abstract 1493: Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics

John G. Yuen, Andrew Fesler, Ga-Ram Hwang, Thomas Dahl, Lan-Bo Chen, Henry Chen, Jingfang Ju

Cancer Res (2022) 82 (12_Supplement): 1493.

DOI: https://doi.org/10.1158/1538-7445.AM2022-1493

Published: 15 June 2022

View article

Journal Articles

Abstract 4063: Design and development of a novel 5-FU modified siRNA against BCL2 with enhanced efficacy and the unique ability to be delivered vehicle free into cancer cells

Andrew Fesler, Ga-Ram Hwang, John Yuen, Jingfang Ju

Cancer Res (2020) 80 (16_Supplement): 4063.

DOI: https://doi.org/10.1158/1538-7445.AM2020-4063

Published: 15 August 2020

View article

Journal Articles

Abstract 2592: Development of a novel modified miR-15a mimic with enhanced therapeutic potential for treatment of pancreatic ductal adenocarcinoma

Shixiang Guo, Andrew Fesler, Wenjie Huang, Yunchao Wang, Jiali Yang, Xianxing Wang, Ga-Ram Hwang, Matthew Godwin, Huaizhi Wang, Jingfang Ju

Cancer Res (2019) 79 (13_Supplement): 2592.

DOI: https://doi.org/10.1158/1538-7445.AM2019-2592

Published: 01 July 2019

View article

Journal Articles

Abstract 4403: Development of 5-FU modified tumor suppressor miRNAs as a platform for miRNA based cancer therapeutics

Andrew Fesler, Shixiang Guo, Zachary Ye, Matthew Godwin, Hyaizha Wang, Jingfang Ju

Cancer Res (2018) 78 (13_Supplement): 4403.

DOI: https://doi.org/10.1158/1538-7445.AM2018-4403

Published: 01 July 2018

View article

Journal Articles

Abstract 5443: Developing a novel miR-15a mimic as a potential therapeutic molecule to eliminate resistant colorectal cancer stem cells

Andrew T. Fesler, Hua Liu, Ning Wu, Jingfang Ju

Cancer Res (2017) 77 (13_Supplement): 5443.

DOI: https://doi.org/10.1158/1538-7445.AM2017-5443

Published: 01 July 2017

View article

Journal Articles

Abstract 2141: Development of a novel miR-129 mimic with enhanced therapeutic potential for treatment of resistant colorectal cancer

Andrew T. Fesler, Ning Wu, Hua Liu, Jingfang Ju

Cancer Res (2017) 77 (13_Supplement): 2141.

DOI: https://doi.org/10.1158/1538-7445.AM2017-2141

Published: 01 July 2017

View article

Journal Articles

Abstract 1968: Systematic validation of microRNA based prognostic biomarkers for stage II, III and IV colorectal cancer

Dongling Ma, Yaqi Xue, Andrew Fesler, Haiyan Zhai, Jie Yang, Apisri Ieamniramit, Wenzhe Li, Jingfang Ju

Cancer Res (2016) 76 (14_Supplement): 1968.

DOI: https://doi.org/10.1158/1538-7445.AM2016-1968

Published: 15 July 2016

View article

Journal Articles

Abstract 3117: Hsa-miR-140-5p inhibits colorectal cancer stem cell invasion and metastasis by suppressing Smad2 and autophagy

Haiyan Zhai, Andrew Fesler, Jingfang Ju

Cancer Res (2015) 75 (15_Supplement): 3117.

DOI: https://doi.org/10.1158/1538-7445.AM2015-3117

Published: 01 August 2015

View article

Journal Articles

Abstract 3079: Mechanism of hsa-miR-15a in EMT and chemoresistance in colorectal cancer

Andrew Fesler, Haiyan Zhai, Jingfang Ju

Cancer Res (2015) 75 (15_Supplement): 3079.

DOI: https://doi.org/10.1158/1538-7445.AM2015-3079

Published: 01 August 2015

View article

Journal Articles

Abstract 5247: Comprehensive and systematic identification of miR-215 targets in colon cancer via a novel translation capture immunoprecipitation (TrIP) approach

Andrew Fesler, Xiao Xu, Emily Chen, Jingfang Ju

Cancer Res (2014) 74 (19_Supplement): 5247.

DOI: https://doi.org/10.1158/1538-7445.AM2014-5247

Published: 01 October 2014

View article

Journal Articles

Abstract 1840: Clinical significance of lincRNA-p21 in colorectal cancer.

Haiyan Zhai, Andrew Fesler, Kristina Schee, Øystein Fodstad, Kjersti Flatmark, Jingfang Ju

Cancer Res (2013) 73 (8_Supplement): 1840.

DOI: https://doi.org/10.1158/1538-7445.AM2013-1840

Published: 15 April 2013

View article

Journal Articles

Abstract 5293: Prognostic significance of miR-194 in endometrial cancer.

Haiyan Zhai, Mihriban Karaayvaz, Peixin Dong, Noriaki Sakuragi, Jingfang Ju

Cancer Res (2013) 73 (8_Supplement): 5293.

DOI: https://doi.org/10.1158/1538-7445.AM2013-5293

Published: 15 April 2013

View article

Journal Articles

Abstract 4185: miR-129 is a potential tumor suppressor in colorectal cancer by regulating apoptosis and modulating fluropyrimidine based chemosensitivity.

Mihriban Karaayvaz, Haiyan Zhai, Jingfang Ju

Cancer Res (2013) 73 (8_Supplement): 4185.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4185

Published: 15 April 2013

View article

Journal Articles

Abstract 2285: Inhibition of autophagy and tumor growth in colon cancer by miR-502

Haiyan Zhai, Bo Song, Xiao Xu, Wei Zhu, Jingfang Ju

Cancer Res (2012) 72 (8_Supplement): 2285.

DOI: https://doi.org/10.1158/1538-7445.AM2012-2285

Published: 15 April 2012

View article

Journal Articles

Abstract 158: Expression of miR-205 is significantly associated with prognosis of endometrial cancer

Mihriban Karaayvaz, Cecilia Zhang, Saira Mehmood, Penelope Georgakopoulos, Stephanie Burke, Kenneth Shroyer, Sharon Liang, Jingfang Ju

Cancer Res (2011) 71 (8_Supplement): 158.

DOI: https://doi.org/10.1158/1538-7445.AM2011-158

Published: 15 April 2011

View article

Journal Articles

Abstract 2263: Prognostic significance of miR-215 in colon cancer

Mihriban Karaayvaz, Timothy Pal, Bo Song, Cecilia Zhang, Penelope Georgakopoulos, Saira Mehmood, Stephanie Burke, Kenneth Shroyer, Jingfang Ju

Cancer Res (2011) 71 (8_Supplement): 2263.

DOI: https://doi.org/10.1158/1538-7445.AM2011-2263

Published: 15 April 2011

View article

Journal Articles

Abstract 1143: Translational control analysis by translationally active RNA capture/microarray analysis (TrIP-Chip)

Kenji Kudo, Yaguang Xi, Yuan Wang, Bo Song, Edward Chu, Jingyue Ju, James J. Russo, Jingfang Ju

Cancer Res (2010) 70 (8_Supplement): 1143.

DOI: https://doi.org/10.1158/1538-7445.AM10-1143

Published: 15 April 2010

View article

Journal Articles

Abstract 2103: miR-140 and miR-192 are potential tumor suppressors through inhibiting cellular proliferation and restoring cell cycle control in breast cancer cell lines

Bo Song, Mihriban Karaayvaz, Jingfang Ju

Cancer Res (2010) 70 (8_Supplement): 2103.

DOI: https://doi.org/10.1158/1538-7445.AM10-2103

Published: 15 April 2010

View article

Journal Articles

Abstract 1984: A novel logistic regression model for microRNA microarray normalization

Bin Wang, Paul Howell, Xiaofeng Wang, Xuemin Qian, Kun Huang, Adam Riker, Jingfang Ju, Yaguang Xi

Cancer Res (2010) 70 (8_Supplement): 1984.

DOI: https://doi.org/10.1158/1538-7445.AM10-1984

Published: 15 April 2010

View article

NARROW

Abstract 1490: Development of a 5-FU modified miR-129 mimic as a novel therapeutic for non-small cell lung cancer

Abstract 1493: Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics

Abstract 4063: Design and development of a novel 5-FU modified siRNA against BCL2 with enhanced efficacy and the unique ability to be delivered vehicle free into cancer cells

Abstract 2592: Development of a novel modified miR-15a mimic with enhanced therapeutic potential for treatment of pancreatic ductal adenocarcinoma

Abstract 4403: Development of 5-FU modified tumor suppressor miRNAs as a platform for miRNA based cancer therapeutics

Abstract 5443: Developing a novel miR-15a mimic as a potential therapeutic molecule to eliminate resistant colorectal cancer stem cells

Abstract 2141: Development of a novel miR-129 mimic with enhanced therapeutic potential for treatment of resistant colorectal cancer

Abstract 1968: Systematic validation of microRNA based prognostic biomarkers for stage II, III and IV colorectal cancer

Abstract 3117: Hsa-miR-140-5p inhibits colorectal cancer stem cell invasion and metastasis by suppressing Smad2 and autophagy

Abstract 3079: Mechanism of hsa-miR-15a in EMT and chemoresistance in colorectal cancer

Abstract 5247: Comprehensive and systematic identification of miR-215 targets in colon cancer via a novel translation capture immunoprecipitation (TrIP) approach

Abstract 1840: Clinical significance of lincRNA-p21 in colorectal cancer.

Abstract 5293: Prognostic significance of miR-194 in endometrial cancer.

Abstract 4185: miR-129 is a potential tumor suppressor in colorectal cancer by regulating apoptosis and modulating fluropyrimidine based chemosensitivity.

Abstract 2285: Inhibition of autophagy and tumor growth in colon cancer by miR-502

Abstract 158: Expression of miR-205 is significantly associated with prognosis of endometrial cancer

Abstract 2263: Prognostic significance of miR-215 in colon cancer

Abstract 1143: Translational control analysis by translationally active RNA capture/microarray analysis (TrIP-Chip)

Abstract 2103: miR-140 and miR-192 are potential tumor suppressors through inhibiting cellular proliferation and restoring cell cycle control in breast cancer cell lines

Abstract 1984: A novel logistic regression model for microRNA microarray normalization

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only